7NEWS.com.au - 03 Oct 2020
President Donald Trump is receiving an experimental antiviral for COIVD-19 called remdesivir as he remains hospitalised at Walter Reed National Military ...
The Lancet - 15 Jul 2024
Comparative effectiveness of combination therapy with nirmatrelvir–ritonavir and remdesivir versus monotherapy with remdesivir or nirmatrelvir–ritonavir in patients hospitalised with COVID-19: a target trial emulation study ...
Nature.com - 23 Apr 2024
Real life experience on the use of Remdesivir in patients admitted to COVID-19 in two referral Italian hospital: a propensity score matched analysis ...
Frontiers - 25 Jun 2024
Real-world evidence of survival benefit of remdesivir: study of 419 propensity score-matched patients hospitalized over the alpha and delta waves of COVID-19 in New Orleans, LA ...
ACS Publications - 04 May 2020
Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19 ...
Nature.com - 05 Mar 2024
Comparable outcomes of outpatient remdesivir and sotrovimab among high-risk patients with mild to moderate COVID-19 during the omicron BA.1 surge ...
Nature.com - 21 Aug 2024
An in vitro study for reducing the cytotoxicity and dose dumping risk of remdesivir via entrapment in nanostructured lipid carriers ...